University of Rhode Island

DigitalCommons@URI
Senior Honors Projects

Honors Program at the University of Rhode
Island

5-2018

Genetic Testing and a Real World Case of Lynch Syndrome
Paige Montanaro
paige_montanaro@my.uri.edu

Follow this and additional works at: https://digitalcommons.uri.edu/srhonorsprog
Part of the Biochemistry Commons, Cancer Biology Commons, Genetics Commons, and the
Molecular Biology Commons

Recommended Citation
Montanaro, Paige, "Genetic Testing and a Real World Case of Lynch Syndrome" (2018). Senior Honors
Projects. Paper 641.
https://digitalcommons.uri.edu/srhonorsprog/641

This Article is brought to you for free and open access by the Honors Program at the University of Rhode Island at
DigitalCommons@URI. It has been accepted for inclusion in Senior Honors Projects by an authorized administrator
of DigitalCommons@URI. For more information, please contact digitalcommons@etal.uri.edu.

Genetic Testing and a Real World Case of Lynch Syndrome
Paige Montanaro – Cell and Molecular Biology
Sponsor: Dr. Joel Chandlee

Introduc(on
In recent years, advancements in gene(c
tes(ng methods have revolu(onized the
medical ﬁeld by enhancing the ability to
iden(fy persons with an inherited
predisposi(on to cancer. This project was
designed to inves(gate the methods used in
gene(c tes(ng as well as demonstrate the
importance of implemen(ng gene(c tests to
individuals who appear to be at risk for
cancer.

Results
Gene$c Tes$ng

Lynch Syndrome

Lynch syndrome, or hereditary nonpolyposis colon cancer (HNPCC), is an
autosomal dominant disease that leads to
colon cancer as well as increased risk to
many other cancers due to the inac(va(on
or altered func(on of integral DNA
mismatch repair genes.

Classiﬁca1on of the 3 main types of gene1c tes1ng (1).

Gene(cists search for speciﬁc markers within the
human genome that are indicators of an inherited
cancer syndrome.

Methods
To complete this project, I did research on the
methods used in gene(c tes(ng, speciﬁcally for
those with an inherited predisposi(on to cancer.
To supplement this research, a real world case
study was evaluated. An individual who
underwent the Myriad myRisk® gene(c test and
presented with a muta(on known as Lynch
Syndrome was studied. I produced an inclusive
research paper that highlights the posi(ve impact
of gene(c tes(ng by dissec(ng the pathogenesis
of Lynch Syndrome at a molecular level.

Cytogene1c loca1on of MLH1 gene on chromosome 3 3p22.2 (3).

Case Study

PaLern of inheritance in Lynch Syndrome families

The pa(ent underwent the Myriad myRisk® test, which
uncovered a gene(c muta(on in her genome classiﬁed
as Lynch Syndrome. Tes(ng revealed the muta(on c.
113del (p.Thr45Glnfs*5). This muta(on results in
premature trunca(on of the MLH1 protein.

• Mismatch repair genes mutated in LS:
MLH1, MSH2, MSH6, PMS2, EPCAM
• 3-5% of colorectal cancers arise from LS
• One of the most common hereditary
cancer syndromes
• Increased risk of many abdominal and
reproduc(ve cancers
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The Myriad myRisk® Hereditary Cancer Test is a 28-gene panel that
iden1ﬁes an elevated risk for 8 cancers (2).
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